Head‐to‐head comparison of two online nomograms for prostate biopsy outcome prediction

M Oliveira, V Marques, AP Carvalho… - BJU international, 2011 - Wiley Online Library
Study Type–Diagnosis (exploratory cohort) Level of Evidence 2b What's known on the
subject? and What does the study add? In recent years, several nomograms were …

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression‐based model, the prostate cancer risk calculator, and prostate‐specific antigen …

DJ Hernandez, M Han, EB Humphreys… - BJU …, 2009 - Wiley Online Library
OBJECTIVES To develop a logistic regression‐based model to predict prostate cancer
biopsy at, and compare its performance to the risk calculator developed by the Prostate …

Multicenter European external validation of a Prostate Health Index–based nomogram for predicting prostate cancer at extended biopsy

G Lughezzani, M Lazzeri, A Haese, T McNicholas… - European urology, 2014 - Elsevier
Background External validation of a prediction tool is mandatory to assess the tool's
accuracy and generalizability within different patient cohorts. Objective To externally validate …

A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy

I Ouzaid, DR Yates, V Hupertan, P Mozer… - The …, 2012 - Wiley Online Library
BACKGROUND Several tools have been developed to predict the outcome of prostate
biopsies performed to diagnosis prostate cancer (PCa). However, few studies have focused …

Initial biopsy outcome prediction—head-to-head comparison of a logistic regression-based nomogram versus artificial neural network

FKH Chun, M Graefen, A Briganti, A Gallina, J Hopp… - European urology, 2007 - Elsevier
OBJECTIVES: Nomograms and artificial neural networks (ANNs) represent alternative
methodologic approaches to predict the probability of prostate cancer on initial biopsy. We …

External evaluation of a novel prostate cancer risk calculator (ProstateCheck) based on data from the Swiss arm of the ERSPC

C Poyet, MS Wettstein, DJ Lundon, B Bhindi… - The Journal of …, 2016 - Elsevier
Purpose We externally validated a novel prostate cancer risk calculator based on data from
the Swiss arm of the ERSPC and assessed whether the risk calculator (ProstateCheck) is …

The next generation of clinical decision making tools: development of a real-time prediction tool for outcome of prostate biopsy in response to a continuously evolving …

AN Strobl, IM Thompson, AJ Vickers, DP Ankerst - The Journal of urology, 2015 - Elsevier
Purpose We evaluate whether annual updating of the PCPT Risk Calculator would improve
institutional validation compared to static use of the PCPT Risk Calculator alone. Materials …

Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy

G Lughezzani, M Lazzeri, A Larcher, G Lista… - The Journal of …, 2012 - auajournals.org
Purpose: We developed and validated a Prostate Health Index (Beckman Coulter, Brea,
California) based nomogram to predict prostate cancer at extended prostate biopsy …

Comparison of two prostate cancer risk calculators that include the prostate health index

MJ Roobol, MM Vedder, D Nieboer, A Houlgatte… - European urology …, 2015 - Elsevier
Background Risk prediction models for prostate cancer (PCa) have become important tools
in reducing unnecessary prostate biopsies. The Prostate Health Index (PHI) may increase …

Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy-and prostate volume-adjusted …

M Nomura, K Ito, M Miyakubo, Y Sekine… - Prostate cancer and …, 2012 - nature.com
Background: We previously reported the diagnostic efficacy of the age-and prostate volume-
adjusted prostate biopsy method (the adjusted biopsy method). Here, we developed a new …